James George Chopas - 21 Jan 2022 Form 4/A - Amendment Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
VP/Chief Accounting Officer
Signature
/s/ David Watson, attorney-in-fact
Issuer symbol
APLS
Transactions as of
21 Jan 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
07 Feb 2022, 19:06:32 UTC
Date Of Original Report
25 Jan 2022
Previous filing
27 Oct 2021
Next filing
31 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Award $0 +10,657 +126% $0.000000 19,139 21 Jan 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option (right to buy) Award $0 +15,116 $0.000000 15,116 21 Jan 2022 Common Stock 15,116 $35.46 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a restricted stock unit grant made on January 21, 2022 that vests 25% annually in equal installments over four years from the date of grant, subject to continued service.
F2 On January 23, 2021, the reporting person filed a Form 4 that inadvertently reported that the reporting person was granted a restricted stock unit of 6,974 shares. This amendment is being filed solely to correct such number of shares to 10,657.
F3 This represents a non-qualified stock option grant made on January 21, 2022 that vests over a four year period with 25% vesting one year from grant date and the remaining 75% vesting in equal monthly installments thereafter through the fourth anniversary of the grant date, subject to continued service.
F4 On January 23, 2021, the reporting person filed a Form 4 that inadvertently reported that the reporting person was granted a non-qualified stock option grant of 9,892 shares. This is amendment is being filed solely to correct such number of shares to 15,116.